1. Home
  2. CCCC vs GAIA Comparison

CCCC vs GAIA Comparison

Compare CCCC & GAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCC
  • GAIA
  • Stock Information
  • Founded
  • CCCC 2015
  • GAIA 1988
  • Country
  • CCCC United States
  • GAIA United States
  • Employees
  • CCCC N/A
  • GAIA N/A
  • Industry
  • CCCC Biotechnology: Pharmaceutical Preparations
  • GAIA Movies/Entertainment
  • Sector
  • CCCC Health Care
  • GAIA Consumer Discretionary
  • Exchange
  • CCCC Nasdaq
  • GAIA Nasdaq
  • Market Cap
  • CCCC 115.0M
  • GAIA 110.5M
  • IPO Year
  • CCCC 2020
  • GAIA 1999
  • Fundamental
  • Price
  • CCCC $1.47
  • GAIA $4.98
  • Analyst Decision
  • CCCC Buy
  • GAIA Strong Buy
  • Analyst Count
  • CCCC 3
  • GAIA 2
  • Target Price
  • CCCC $12.00
  • GAIA $8.00
  • AVG Volume (30 Days)
  • CCCC 943.9K
  • GAIA 52.0K
  • Earning Date
  • CCCC 07-31-2025
  • GAIA 05-12-2025
  • Dividend Yield
  • CCCC N/A
  • GAIA N/A
  • EPS Growth
  • CCCC N/A
  • GAIA N/A
  • EPS
  • CCCC N/A
  • GAIA N/A
  • Revenue
  • CCCC $39,783,000.00
  • GAIA $92,889,000.00
  • Revenue This Year
  • CCCC N/A
  • GAIA $13.93
  • Revenue Next Year
  • CCCC N/A
  • GAIA $15.16
  • P/E Ratio
  • CCCC N/A
  • GAIA N/A
  • Revenue Growth
  • CCCC 98.56
  • GAIA 13.15
  • 52 Week Low
  • CCCC $1.09
  • GAIA $2.93
  • 52 Week High
  • CCCC $7.66
  • GAIA $6.53
  • Technical
  • Relative Strength Index (RSI)
  • CCCC 51.01
  • GAIA 54.91
  • Support Level
  • CCCC $1.21
  • GAIA $4.25
  • Resistance Level
  • CCCC $1.57
  • GAIA $5.37
  • Average True Range (ATR)
  • CCCC 0.12
  • GAIA 0.28
  • MACD
  • CCCC 0.02
  • GAIA 0.04
  • Stochastic Oscillator
  • CCCC 70.27
  • GAIA 65.18

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About GAIA Gaia Inc.

Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. Geographically, it derives a majority of its revenue from the United States and also has an International presence.

Share on Social Networks: